Piramal expands route scouting offering to meet demand
Piramal’s ‘route
scouting’ service helps customers rapidly identify robust, cost effective
routes to manufacture Active Pharmaceutical Ingredients (API). The company’s
scientists offer their expertise to develop routes from late preclinical
through clinical development, that are shorter and safer, and more
cost effective, atom efficient, and environmentally-friendly, than conventional
methods of API production. The success of this service since its launch last
year has encouraged Piramal to expand this offering to additional sites while
augmenting its technology platform.
Scaling up and
manufacturing complex intermediates and APIs pose significant challenges when
working with tight deadlines, typically associated with clinical development
and commercialization of new products. To address these challenges, many
pharmaceutical and biotech companies look for support from external partners.
Piramal’s ‘Route Scouting’ offering seeks to fulfil this need.
Piramal’s Route
Scouting Strategy focuses on a Fit for Purpose (FFP) approach that serves
customers from discovery through commercialization, and through life cycle
management. Introduced in 2015, this service targeted biotech clients who
needed to develop robust routes to scale up medicinal chemistry processes and
rapidly manufacture material for preclinical Tox. The service was initially
offered out of Piramal’s Ahmedabad, India site, and was staffed with process
scientists with several years of experience in developing novel chemistries.
The number of clients and projects expanded rapidly, with large pharmaceutical
clients also signing up for the service. The team has now tackled issues from
preclinical through commercialization in the past 18 months. Some of them
include:
·
"I have a medicinal chemistry route ... I now need to make my
first 100-250 g for GLP tox."
·
"I need a robust route for Tox/Ph I ... my route uses
reagents that are expensive, toxic or not available in bulk."
·
"I have multiple chromatographic separations leading to
significant loss in yields."
·
"I want to reduce the number of steps, or decrease the cycle
time to release capacity."
·
"I am going to face generic competition and need a cost
effective route, at scale, to be competitive."
Piramal is now
working with more than 15 companies, from large pharmaceuticals to virtual
biotechs, on over 20 projects that involve developing routes for clinical
development and commercialization. Piramal has now expanded this offering from
Ahmedabad (India), to its sites in Michigan (USA), Aurora (Canada), and Ennore
(India). In addition, the company has married this initiative with additions to
its technology platforms: Piramal has invested in (a) Advanced Flow Reactors
for continuous flow route development, and (b) established a chemocatalyst and
biocatalyst Centre of Excellence, where commercial catalyst technologies can be
levered to provide customized solutions.
Ramesh Subramanian,
Vice President, Strategic Marketing at Piramal concluded, “Piramal route
scouting focuses on providing tailored solutions for clients. Once the route is
developed, our clients own the route and the API can be manufactured at any
site of their choice. While this flexibility is appreciated, in practice we
find that a vast majority of clients choose to manufacture at Piramal. Our
track record of 34 successful product launches, with 10 potential additional
launches this year, gives them confidence in our abilities. In addition, they
appreciate the seamless tech transfer towards larger volumes of intermediates
or API, that Piramal offers. This, combined with a world class program
management system, that supports clinical/commercial API supplies from our
sites across the globe appeals to our collaborators. Feedback from one of our
collaborators sums this up well: ‘Piramal was the only firm we found that has a
dedicated service to develop novel routes cost effectively while integrating it
seamlessly with downstream manufacturing facilities in North America, Europe,
and Asia”
Published: February 20, 2017
http://www.specchemonline.com/news/piramal-expands-route-finding-network
No comments:
Post a Comment